Eyenovia logo

Eyenovia Share Price Today (NASDAQ: EYEN)

Eyenovia share price is $15.8 & ₹1,347.93 as on 30 Jun 2025 IST

$15.8

▲

5.24

(49.62%)

Live

Bell Icon

The stock has been delisted from the stock exchange on 1 Jul 2025

View live Eyenovia share price in Dollar and Rupees. Guide to invest in Eyenovia stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Eyenovia, along with analyst recommendations, forecasts, and comprehensive financials.

Eyenovia (EYEN) Key Statistics

in dollars & INR

Previous Close
$10.56
Open
$10.845
Market Capitalization
$53.0M
Today's Volume
$1.2M
Revenue TTM
$67.1K
EBITDA
$-29.1M
Earnings Per Share (EPS)
$-42.65
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-388.03%

How to invest in Eyenovia Stock (EYEN) from India?

It is very easy for Indian residents to invest directly in Eyenovia from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Eyenovia stock in both Indian Rupees (INR) and US Dollars (USD). Search for Eyenovia or EYEN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Eyenovia or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Eyenovia shares which would translate to 0.054 fractional shares of Eyenovia as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Eyenovia, in just a few clicks!

Indian investors sentiment towards Eyenovia (EYEN)

500.0%

Period: Jun 2, 2025 to Jul 2, 2025. Change in 30 Days versus previous period

Investment in Eyenovia Shares from India has grown by 500.0% over the past 30 days, indicating increased transactional activity.

Global Institutional Holdings in Eyenovia

  • UBS Group AG

    6.91%

  • Lasry Marc

    1.06%

  • Virtu Financial LLC

    0.80%

  • Citadel Advisors Llc

    0.43%

  • Geode Capital Management, LLC

    0.36%

  • BlackRock Inc

    0.04%

Analyst Recommendation on Eyenovia

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Eyenovia(by analysts ranked 0 to 5 stars)

Eyenovia Technicals Summary

Sell

Neutral

Buy

Eyenovia is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

About Eyenovia

Eyenovia, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi; and agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.
Organization
Eyenovia
Employees
13
CEO
Mr. Michael M. Rowe
Industry
Health Technology

Management People of Eyenovia

NameTitle
Mr. Michael M. Rowe
Principal Financial Officer, CEO, President & Director
Dr. Tsontcho Ianchulev M.D., M.P.H., MPH
Co-Founder & Executive Director
Mr. Bren Kern
Chief Operating Officer
Mr. Norbert Lowe
Senior Vice President of Commercial Operations
Mr. Enrico Brambilla
Senior Vice President of R&D
Alexander Lobo
Investor Contact

Important FAQs about investing in EYEN Stock from India :

Can Indians buy Eyenovia shares?

Yes, Indians can invest in the Eyenovia (EYEN) from India.

With INDmoney, you can buy Eyenovia at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Eyenovia at zero transaction cost.

How can I buy Eyenovia shares from India?

It is very easy to buy Eyenovia from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Eyenovia (EYEN) be purchased?

Yes, you can buy fractional shares of Eyenovia with INDmoney app.

What are the documents required to start investing in Eyenovia stocks?

To start investing in Eyenovia, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Eyenovia?

Today's market capitalisation of Eyenovia EYEN is 53.0M

Who is the Chief Executive Officer (CEO) of Eyenovia ?

Mr. Michael M. Rowe is the current Chief Executive Officer (CEO) of Eyenovia.